tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease Treatment
PremiumCompany AnnouncementsAmicus Therapeutics’ Migalastat Study: A Potential Game-Changer for Fabry Disease Treatment
23d ago
Amicus Therapeutics Expands Access to Migalastat for Fabry Disease Patients
Premium
Company Announcements
Amicus Therapeutics Expands Access to Migalastat for Fabry Disease Patients
23d ago
Amicus Therapeutics Completes Key Study on Pompe Disease Treatment Interactions
Premium
Company Announcements
Amicus Therapeutics Completes Key Study on Pompe Disease Treatment Interactions
30d ago
Amicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
PremiumRatingsAmicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
3M ago
Amicus Therapeutics Reports Strong Q1 2025 Growth
Premium
Company Announcements
Amicus Therapeutics Reports Strong Q1 2025 Growth
3M ago
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
Premium
Ratings
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
3M ago
Amicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
PremiumPre-EarningsAmicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100